⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAR News
Pharming Group N.V. ADS, each representing 10 ordinary shares
Pharming Group N.V. (PHAR) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
PHAR
PHAR Investor Alert: Levi & Korsinsky Investigates Pharming Group N.V. (PHAR) for Potential Securities Fraud
accessnewswire.com
PHAR
Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
PHAR
Levi & Korsinsky Announces Investigation of Securities Claims Against Pharming Group N.V. (PHAR)
accessnewswire.com
PHAR
PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group
prnewswire.com
PHAR
Levi & Korsinsky Announces Investigation of Securities Claims Against Pharming Group N.V. (PHAR)
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
PHAR
PHAR SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Pharming Group N.V. for Possible Securities Law Violations
accessnewswire.com
PHAR
Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)
prnewswire.com
PHAR
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
globenewswire.com
PHAR